Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: The outcome after combined-modality therapy

被引:16
作者
Boscolo-Rizzo, Paolo
Gava, Alessandro
Da Mosto, Maria Cristina
机构
[1] Univ Padua, Treviso Reg Hosp, Sch Med, ENT Dept, I-35100 Padua, Italy
[2] Univ Padua, Treviso Reg Hosp, Sch Med, Reg Ctr Head & Neck Ctr, I-35100 Padua, Italy
[3] Treviso Reg Hosp, Dept Radiat Oncol, Treviso, Italy
关键词
occult primary; unknown primary; head and neck cancer; treatment; radiotherapy; neck dissection;
D O I
10.1245/s10434-006-9329-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of this retrospective analysis was to analyze the results of treatment of patients with cervical node metastases from carcinoma of occult primary with a policy including neck dissection and postoperative comprehensive radiotherapy. Methods: Ninety patients were treated with curative intent from 1990 to 2002. Results: The actuarial rate of neck disease control was 68.8% at 5 years (95% confidence interval [CI], 58.9%-78.7%). On multivariate analysis, the rate of neck disease control was significantly related to lymph nodal metastatic level (P = .006). The actuarial rate of developing head and neck primary tumors at 5 years was 8.9% (95% CI, 2.6%-15.2%). The 5-year actuarial rate of distant metastases was 19.1% (95% CI, 9.4%-28.9%). In multivariate analysis, a statistically significant difference in the rate of distant metastasis was obtained when patients were stratified according to the level of nodal involvement (P = .01) and the presence of extracapsular extension (P = .013). At the time of analysis, 50 of the 90 patients were alive. A total of 32 (35.6%) had died from causes related to their primary disease. Actuarial disease-specific survival at 2 and 5 years was 73.6% (95% CI, 64.3%-82.9%) and 62.8% (95% CI, 51.9%-73.7%), respectively. In multivariate analysis, a statistically significant difference in disease-specific survival was obtained when patients were stratified according to the level of nodal involvement and the presence of extracapsular extension. Conclusions: Our study seems to support the use of combined-modality therapy in patients with neck metastases from carcinoma of occult primary. However, in the absence of randomized trials, comprehensive irradiation cannot be routinely advised.
引用
收藏
页码:1575 / 1582
页数:8
相关论文
共 32 条
[1]  
[Anonymous], 2010, TNM CLASSIFICATION M
[2]  
BATAINI JP, 1987, LARYNGOSCOPE, V97, P1080
[3]  
BERKER JL, 2000, INT J RADIAT ONCOL, V48, P320
[4]  
BRIASOULIS E, 1997, ONCOLOGIST, V2, P142
[5]   METASTASES TO LYMPH-NODES OF HEAD AND NECK FROM AN UNKNOWN PRIMARY SITE [J].
COKER, DD ;
CASTERLINE, PF ;
CHAMBERS, RG ;
JAQUES, DA .
AMERICAN JOURNAL OF SURGERY, 1977, 134 (04) :517-522
[6]   CERVICAL NODAL METASTASIS OF SQUAMOUS-CELL CARCINOMA OF UNKNOWN ORIGIN - INDICATIONS FOR WITHHOLDING RADIATION-THERAPY [J].
COSTER, JR ;
FOOTE, RL ;
OLSEN, KD ;
JACK, SM ;
SCHAID, DJ ;
DESANTO, LW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992, 23 (04) :743-749
[7]   CERVICAL METASTASES OF OCCULT ORIGIN - THE IMPACT OF COMBINED-MODALITY THERAPY [J].
DAVIDSON, BJ ;
SPIRO, RH ;
PATEL, S ;
PATEL, K ;
SHAH, JP .
AMERICAN JOURNAL OF SURGERY, 1994, 168 (05) :395-399
[8]  
DAVIDSON JD, 1999, HEAD NECK CANC MULTI, P391
[9]  
De B. K., 1993, Journal of the Indian Potato Association, V20, P273
[10]   Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection [J].
Erkal, HS ;
Mendenhall, WM ;
Amdur, RJ ;
Villaret, DB ;
Stringer, SP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (01) :55-63